EDAP TMS Investor Relations Material

EDAP TMS S.A. is a medical technology company specializing in the development, manufacturing, and distribution of minimally invasive therapeutic ultrasound devices. The company focuses on treatments for urological conditions, particularly prostate diseases, using high-intensity focused ultrasound (HIFU) technology. EDAP’s products include devices for prostate ablation and lithotripsy, providing non-invasive treatment options that reduce recovery times and side effects for patients. The company markets its products to hospitals and clinics globally, supporting advancements in therapeutic ultrasound technology. The company is headquartered in Lyon, France, and its shares are listed on the NASDAQ.